W
hether mammalian hearts harbor a population of intrinsic stem cells for myocardial renewal and repair and, if they do, how to identify these cells for use in cell-based therapy for heart failure are central questions in cardiac regenerative medicine. [1] [2] [3] [4] [5] In the past 2 decades, tremendous efforts have been made to search for such cells, and many forms of cardiac stem cells (CSCs) have been identified. 1, 2 Recently, the nature of c-Kit + CSCs and their function in heart repair were questioned. [6] [7] [8] [9] [10] Three independent groups coincidentally indicated that cardiac c-Kit + cells lack myogenic potential during heart development and repair. [11] [12] [13] Murine stem cell antigen-1 (Sca-1) is a member of the Ly-6 gene family (gene name Ly6a). 14, 15 Sca-1 encodes a cell surface protein widely used to enrich hematopoietic stem cells from the bone marrow (BM). 14, 16 With this perception, Sca-1 has been persistently thought to be a marker to identify adult stem cells in multiple organs. [17] [18] [19] [20] [21] Cardiac Sca-1 + cells were among the first putative CSCs identified in the adult mouse heart, [22] [23] [24] [25] [26] and are found distributed in diverse CSC subtypes in mice (eg, cardiospheres, side populations, and cardiac colony-forming unit fibroblasts). [27] [28] [29] [30] [31] [32] The human equivalent of the murine Sca-1 ortholog was not identified. However, Sca-1 + -like cells were isolated from the adult human heart using an anti-mouse Sca-1 antibody and showed cardiomyogenic potential when cultured in vitro. 33 Importantly, a phase I clinical trial (CADUCEUS [Cardiosphere-Derived Autologous Stem Cells to Reverse VentricUlar Dysfunction]) was performed in which autologous Sca-1-related cardiosphere-derived cells were administered to patients with myocardial infarction. Reduced scar size with improved cardiac function was observed in the patients. 34 Despite these findings, questions have been raised regarding the mechanisms of Sca-1 + cells in heart repair. In transplantation of exogenously expanded Sca-1 + cells, the number of identifiable engrafted cells has been found to be extremely low (<0.5%), and thus, they are unlikely to contribute to functional heart repair through myocardial differentiation. 35 The myogenic potential of engrafted Sca-1 + cells may also require further investigation because the conclusions are mainly based on immunostaining with potential microscopic artifacts. 36, 37 In addition, previous reports determining the myogenic potential of cardiac Sca-1 + cells have largely relied on in vitro cardiomyogenic differentiation culture procedures and that may not represent the nature of endogenous Sca-1 + cells. 23, 30 Furthermore, the developmental origin of cardiac Sca-1 + cells remains largely unknown. These questions raise doubts about whether Sca-1 expression marks bona fide embryonic or adult CSCs. 38 In summary, there is an urgent need to define the authentic identity of Sca-1 + cells in the developing and adult hearts, to provide definitive answers as to whether Sca-1 expression represents a true and applicable CSC population for heart repair.
METHODS
The data, analytical methods, and study materials will be made available to other researchers for the purposes of reproducing the results or replicating the procedure upon reasonable request. Inquiries can be directed to the corresponding author.
Mouse Models
All mouse experiments were conducted in accordance with an approved Institutional Animal Care and Use Committee protocol at the Icahn School of Medicine at Mount Sinai and were in compliance with institutional and governmental regulations (Public Health Service Animal Welfare Assurance A3111-01). 
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What Are the Clinical Implications?
• The identity of cardiac Sca-1 + cells is endothelium.
• Mechanisms of transplanted Sca-1 + cells in heart repair need to be re-evaluated.
X-gal Staining
Mouse tissues were isolated in ice-cold PBS and fixed in 4% paraformaldehyde for 30 minutes at 4°C. After fixation, the tissues were washed 3 times with PBS and incubated in X-gal solution (5 mmol/L potassium ferricyanide, 5 mmol/L potassium ferrocyanide, 2 mmol/L MgCl 2 , and 1 mg/mL X-gal) overnight at room temperature (RT). For section staining, after fixation, the tissues were treated with 30% sucrose overnight at 4°C and embedded in optimal cutting temperature compound (Tissue-Tek, 4583) on dry ice. Ten-µm sections were cut and postfixed in 4% paraformaldehyde for 5 minutes. The sections were stained with X-gal solution overnight at 37°C.
Immunofluorescence
Mouse tissues were perfused with 4% paraformaldehyde, dehydrated with sucrose, and embedded in optimal cutting temperature compound. Embedded tissues were cut into 10-µm sections. Sections were blocked with 10% donkey serum (Sigma, D9663) in PBS for 1 hour at RT and incubated with primary antibodies overnight at 4°C. The primary antibodies were goat anti-platelet endothelial cell adhesion molecule (PECAM) (CD31; 1:50, R&D Systems, AF3628) and rat anti-Sca-1 (1:200, BD Biosciences, 553333). Sections were then incubated with secondary antibodies for 1 hour at RT. The secondary antibodies used were donkey anti-goat Alexa Fluor 488 (1:500; Invitrogen) and donkey antirat Alexa Fluor 594 (1:500; Invitrogen). Stained sections were mounted with Vectashield mounting medium with 4´,6-diamidino-2-phenylindole (Vector Laboratories). Immunofluorescence images were obtained using a Leica fluorescence microscope.
A Tyramide Signal Amplification plus Fluorescein System (Perkin Elmer, NEL741001KT) was used to amplify Sca-1 antibody fluorescent signals when necessary. After primary antibody incubation, a horseradish peroxidase-conjugated secondary antibody was applied for 1 hour at RT. Horseradish peroxidase-conjugated donkey anti-rat IgG (1:1000; Invitrogen, A18745) was used as the secondary antibody. Sections were washed 3 times in TrisHCl/NaCl/Tween-20 buffer and amplified with Tyramide Signal Amplification Plus Working Solution for 10 minutes at RT.
Myocardial Infarction
Myocardial infarction was induced by ligation of the left anterior descending (LAD) coronary artery as previously described. 43 Briefly, 8-to 16-week-old mice were anesthetized with 4% isoflurane before intubation. The left thoracic region was trimmed with an electric razor and sterilized with 70% isopropanol. After thoracotomy, an 8-0 nylon suture was placed to ligate the LAD. The ribcage and muscle layers were closed with 5-0 polypropylene sutures. Excess air and blood were removed from the chest cavity, and the skin was closed with 4-0 polypropylene sutures. The intubation tube was removed, and mice were housed with moist food and a water bottle.
Heart Perfusion and Flow Cytometry
The procedure for preparing single nonmyocardial cells from murine hearts was described previously. 12 Before surgery, mice were injected with heparin. Animals were anesthetized by isoflurane inhalation. Hearts were perfused with Ca 2+ -free collagenase type II solution. Atria and connective tissues were removed. Ventricles were cut into small pieces and gently dissociated into single cells with a Pasteur pipette. Dissociated single cells were transferred into a 50-mL Falcon tube and centrifuged at 10g for 5 minutes. Cardiomyocytes formed a cell pellet on the bottom. Noncardiomyocytes were harvested and transferred into a new tube without disturbing the cardiomyocyte pellets. The cells were centrifuged at 300g for 5 minutes and resuspended and incubated in 5 to 10 mL of 1X red blood cell lysis buffer at RT for 10 minutes to remove red blood cells. The cells were collected, washed twice, and resuspended in PBS with 0.5% BSA for flow cytometry analysis.
Bone Marrow Flow Cytometry
Flow cytometric analyses were performed as we previously described. 44 Mice (8 weeks old) were euthanized for BM cell collection. Single-cell suspensions derived from the BM were stained with panels of fluorochrome-conjugated antibodies (Sca-1, BD Biosciences 553108; c-Kit, BD Biosciences 560557). Dead cells were excluded by 4´,6-diamidino-2-phenylindole staining. Analyses were performed using an LSRII flow cytometer. All data were analyzed using FlowJo7.6 software.
Statistical Analysis
Results are shown as mean±SEM. Statistical analysis was performed with a Student t test to compare data from individual experimental groups. For each group, 3 to 5 animals or tissue samples were collected for experimentation.
RESULTS
The New Sca-1 H2B-tdTomato Reporter Mouse Recapitulates Endogenous Sca-1 Expression
To characterize the nature of cardiac Sca-1 + cells, we first generated a Sca-1 H2B-tdTomato/+ knock-in mouse model by inserting an H2B-tdTomato cassette into the start codon of Sca-1 (Ly6a) through homologous recombination ( Figure IA in the online-only Data Supplement). In this model, Sca-1 genomic sequences are preserved. Nuclear tdTomato (H2B-tdTomato) expression is under the control of complete Sca-1 regulatory elements, thereby providing a sensitive, robust genetic tool to identify endogenous Sca-1 + cells in developing and adult mouse hearts. All Sca-1 H2B-tdTomato/+ mice were viable and exhibited completely normal development into adulthood (>12 months).
To confirm the fidelity of the knock-in allele, we compared tdTomato with endogenous Sca-1 expression in various organs of Sca-1 H2B-tdTomato/+ mice at postnatal day (P) 60 to 90 (P60-P90). Sca-1 H2B-tdTomato expression colocalized with a Sca-1 antibody in multiple cell types within the kidney, intestine, and lung ( Figure IC through IF in the online-only Data Supplement). With this reporter line, we also detected Sca-1 + cells in the spleen and thymus (data not shown), consistent with previous findings that Sca-1 is expressed in these organs. [45] [46] [47] [48] [49] 
Heterogeneous Sca-1 + Cell Populations in Postnatal Mouse Hearts
Next, we used Sca-1 H2B-tdTomato/+ mice to identify Sca-1 + cells in the heart. Cardiac Sca-1 + cells were found at all postnatal stages inspected (P0, P7, P14, and P30-P360), with a low number and expression level (based on the brightness of H2B-tdTomato) at birth. The number and expression level progressively increased as the heart grew. By P30, Sca-1 H2B-tdTomato -positive cells were dispersed in all cardiac chambers at high density ( Figure 1 ).
Sca-1 + CSCs were initially described as a population of cells lacking the hematopoietic stem cell marker cKit. 22 However, later studies showed that Sca-1 is widely coexpressed with c-Kit in many CSC subtypes (eg, cardiospheres, side populations, and cardiac colony-forming unit fibroblasts). [27] [28] [29] [30] [31] [32] To obtain a definitive answer regarding cardiac Sca- Recently, proepicardial origin cardiac resident colonyforming units-fibroblasts (CFU-Fs) were identified in the adult mouse heart. These cardiac colony-forming unitsfibroblasts express platelet-derived growth factor receptor α (PDGFRα) and Sca-1 and exhibit mesenchymal stem cell properties with multipotency (including cardiomyogenic potential) when cultured in vitro. 32 A new study also showed that PDGFRα + /Sca-1 + side population cells from the adult mouse heart are clonogenic and have the capacity to produce cardiomyocytes, endothelial cells, and smooth muscle cells after cardiac grafting. ;PDGFRα H2B-GFP/+ mouse hearts were examined at P60 through P240. Sca-1 H2B-tdTomato / PDGFRα H2B-GFP double-positive cells were widely observed in all cardiac chambers ( Figure 1F and 1G) . Flow cytometry revealed that ≈49.3% of Sca-1 H2B-tdTomato cells express PDGFRα in a 3-month-old heart ( Figure 1H ).
Exogenously expanded cardiac Sca-1 + cells were shown to express early cardiomyogenic markers, including Nkx2.5, Gata4, and Mef2c, upon treatment with oxytocin. 23 Lineage tracing with a Sca-1 transgenic mouse model also showed that Sca-1 + cells continuously contribute to myocardial turnover during physiological aging at adulthood. 51 If any cardiac resident Sca-1 + cells acts as intrinsic stem cells and provide a progenitor pool for myocardial growth during heart maturation after birth or myocardial turnover during aging at adulthood, we speculate these Sca-1 + cells may transiently express the cardiomyogenic marker Nkx2.5 during progenitor to cardiomyocyte conversion. Therefore, we attempted to determine whether any cardiac Sca-1 + cells simultaneously express Nkx2.5 in postnatal hearts. Nkx2. ) at P30 through P180 (15-to 30-day interval between stages) were thoroughly examined. However, no Sca-1 H2B-tdTomato and cTnT H2B-GFP double-positive cells were found at any of the stages examined ( Figure 1M and 1N) .
Cardiac Resident Sca-1 + Cells Are of the Tie2 Endothelial Lineage
To further determine the identity of Sca-1 + cells throughout heart formation, we generated a dual-reporter mouse line Sca-1 nLacZ-H2B-GFP/+ in which a LoxP-nLacZ4XPolyA-LoxP-H2B-GFP cassette was inserted into the start codon of Sca-1 (Ly6a) through homologous recombination ( Figure IIA and IIB in the online-only Data Supplement). The nLacZ cassette was flanked by two LoxP sites, and thus Sca-1 H2B-GFP expression is initiated when the nlacZ cassette is removed by Cre excision. We performed whole-mount X-gal staining on various tis-+ Cells in Heart Development and Repair Cre excision were colocalized with PECAM ( Figure 2N through 2Q) . These results conclusively suggest that cardiac Sca-1 + cells are purely of the Tie2 endothelial lineage.
Sca-1 Does Not Label Any Cardiac Precursor Cells During Early Embryonic Heart Formation
Currently, the developmental origin of cardiac Sca-1 + cells remains unknown. If resident Sca-1 + cells represent a population of CSCs for myocardial renewal and repair in adulthood, 51 we speculate that Sca-1 could possibly be expressed in early cardiac precursors at mid-late gestation, during which cardiac progenitors from the first and second heart field, proepicardium/ epicardium, and cardiac neural crest progressively migrate and differentiate to form a four-chambered heart with great arteries. [56] [57] [58] Therefore, we performed X-gal staining to search for Sca-1 + cells in embryonic day (E) 7.0 (E7.0) to P0 hearts of Sca-1 nLacZ-H2B-GFP/+ mice. In fact, Sca-1 expression was not detected in any of the early cardiogenic regions (including cardiac crescent at E7.0-E7.5, first and second heart field at E8.0-E9.5, proepicardium/epicardium at E8.0-E16.5, and cardiac neural crest cells at E8.5-E11.5; Figure IIIA 1, 3, 5, 7, 11, 15, 19, 23 , and 27; Figure 3A) , and ROSA26R tdTomato cells were detected throughout the hearts ( Figure 3B ). Immunostaining with an anti-PECAM antibody showed that tdTomato cells are PECAM + (Figure 3C through 3E) , further confirming the endothelial identity of cardiac Sca-1 + cells. Recent lineage tracing of cardiac Sca-1 + cells with a transgenic mouse model carrying a 14-kb Sca-1 regulatory element showed that cardiac Sca-1-derived cardiomyocytes continuously contribute to myocardial replacement during aging, although the frequency is relatively low (an average of 2% to 5% of total cardiomyocytes at 2-18 months). 51 Whether the transgenic mouse model utilized in the study represents the endogenous activity of Sca-1 + cells is unknown. Therefore, we introduced a supersensitive cardiomyocytespecific reporter mouse model, cTnT nlacZ-H2B-GFP/+ , and crossed it with Sca-1
Sca-1 + Cells Minimally Differentiate Into Cardiomyocytes During Homeostasis and Aging
MerCreMer/+ mice. The LoxP-nLacZ4XPloyA-LoxP-H2B-GFP cassette was inserted into the cTnT start codon in cTnT nlacZ-H2B-GFP/+ mice. 40 Bright nuclear GFP (cTnT H2B-GFP ) will be expressed when Cre activity is present in the myocardium or myocardial precursor cells ( Figure 3F ). In the absence of tamoxifen, no GFP hearts (data not shown). We injected tamoxifen into Sca-1 MerCreMer/+ ;cTnT nlacZ-H2B-GFP/+ mice at P30, P60, P90, and P120. After 1 to 2 months of induction, cardiac tissues were collected at P60, P90, P120, and P180 ( Figure 3F ). Very few cTnT H2B-GFP -positive cells were found in the cardiac sections examined: only 12, 6, 4, and 0 cells were detected in whole hearts at P60, P90, P120, and P180, respectively ( Figure 3G ). To increase Sca-1
MerCreMer effectiveness, we administered tamoxifen for 3 months. However, the number of cTnT H2B-GFPpositive cells did not significantly change (altogether <15 cells in the whole heart, ≈0.0012% of total cardiomyocytes). These results suggest that the myogenic potential of cardiac resident Sca-1 + cells is exceedingly low or nonexistent.
Sca-1 + Cells Retain Their Endothelial Identity and Do Not Differentiate Into Cardiomyocytes After Injury
A previous report showed that transplanted cardiac Sca-1 + cells with telomerase activity have the ability to migrate to injured areas of the heart. 22 Lineage tracing in the Sca-1 transgenic mouse model also revealed that cardiac Sca-1 + cells exhibited increased cardiomyocyte differentiation potential under pathological conditions. 51 These observations may need further evaluation because the transplanted Sca- 
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Sca-1 H2B-tdTomato/+ ;cTnT H2B-GFP/+ mice at P60-P150 (Figure 4A through 4G ). These sensitive genetic tools allowed us to precisely locate Sca-1-derived cardiomyogenic progenitors (Sca-1 + /Nkx2.5 + ) or cardiomyocytes (Sca-1 + /cTnT + ) when they were present in the injured zone. Longitudinal sections of the injured heart showed decreased ventricular wall and septum thickness, suggesting acute myocardial infarction ( Figure 4A ;ROSA26R tdTomato/+ double heterozygous mice. Tamoxifen was administered 9 times in 1 month (days 1, 3, 5, 7, 11, 15, 19, 23, and 27) 
signals were detected throughout the injured heart, including the infarcted regions, in these animals (indicating efficient induction), and exhibited enhanced density in the border zone ( Figure 4J1 and 4J2 Figure 4K through 4M) . Only ≈10 cells (≈0.001% of total cardiomyocytes) were found in the entire heart at 30, 60, and 120 dps, and none were located in the injured area ( Figure 4K through 4M ). These observations confirm the extremely low myogenic potential of cardiac resident Sca-1 + cells, and suggest that the myogenic potential of these cells (if any) is not spontaneously stimulated under pathological conditions. In addition, we performed LAD ligation in Sca-1 nLacZ-H2B-GFP/+ ;Tie2
Cre mice (3-6 months old) and found that Sca-1 H2B-GFP -positive cells were distributed in the border zone and infarcted area at 3 to 30 dps, indicating the Sca-1 + cells maintain their endothelial identity after injury ( Figure 4N through 4O ).
DISCUSSION
In this study, we used a series of new mouse models to define the nature of cardiac resident Sca-1 + cells. These high-fidelity genetic tools avoid potential artifacts from immunostaining, provide definitive conclusions regarding the identity and potency of cardiac resident Sca-1 + cells. With these models, we determined that Sca-1 is not expressed in early cardiac precursors during embryonic heart formation. Although cardiac Sca-1 + cells are heterogeneous, they belong to the Tie2 endothelial lineage exclusively, with minimal cardiomyogenic potential under both physiological and pathological conditions. These observations challenge the long-standing dogma that resident Sca-1 + cells are intrinsic CSCs for myocardial development, renewal, and repair.
Previous lineage tracing with transgenic mouse model carrying a 14-kb Sca-1 genomic sequence detected many more Sca-1-derived myocardial cells in the adult mouse heart (≈2% to 5% of total cardiomyocytes) than we observed in this study using a Sca-1
MereCreMer knockin mouse model carrying a complete Sca-1 genomic sequence (≈0.001% of total cardiomyocytes). We presume that a partial Sca-1 genomic fragment does not recapitulate endogenous Sca-1 expression. Use of partial promoter fragments has also confounded previous attempts to lineage-label c-Kit + cells. 59 The extremely low number of Sca-1-derived cardiomyocytes may not even be functionally essential to the heart. These cells may arise from rare, sporadic, and transient Sca-1 expression barely detected in the Sca-1 reporter mice (Sca-1 [60] [61] [62] Whether Tie2 labels a slightly larger cardiac endothelial population than CD31 in the adult mouse heart remains unknown. This requires further investigation in the future.
H2B-tdTomato/+
Over the past 15 years, reports from various groups have repeatedly demonstrated the myogenic potency of cardiac Sca-1 + cells in vitro. Although our study conclusively suggests that endogenous cardiac Sca-1 + cells do not primarily convert to cardiomyocytes, our results are not in opposition to the multipotency of these cells when they are cultured in vitro. We speculate that exogenous expansion of cardiac Sca-1 + cells with specific media and factors may reprogram them and significantly change their nature. The induced multipotency of exogenously expanded Sca-1 + cells does not confirm their cardiomyogenic potential in vivo. Indeed, a study that used transplantation of Sca-1 + cells to the injured heart showed very low efficiency of myocardial conversion. -cells, and human embryonic stem cell-derived cardiomyocytes) were delivered to ischemic hearts revealed that all these cells, regardless of their type or origin, almost equivalently reduced infarct size and improved cardiac function. Based on these observations and the endothelial nature of cardiac Sca-1 + cells, we believe the major beneficial effects of transplanted Sca-1 + cells to injured hearts are not attributable to their cardiomyogenic potential. In the future, it will be interesting to investigate whether and how the paracrine effects or neovascularization of Sca-1 + cells contributes to heart repair given their endothelial identity.
